Introduction {#sec1}
============

Polycystic ovary syndrome (PCOS) is the commonest endocrine disease among women of childbearing age, usually with hyperandrogenism, hyperinsulinism, and cytokine secretion disorder,[@bib1] which affected 5%--15% women during reproductive age.[@bib2] PCOS is thought to be hereditary in nature and caused by multiple factors, such as the lack of androgen's hormonal balance, increased luteinizing hormone (LH), inflammation, and oxidative stress.[@bib3] The problems attending hyperandrogenism, such as ovarian and related metabolic disorders, could be solved by correct diagnosis and therapy, which were not complicated.[@bib4] However, the diagnosis of PCOS remains a challenge,[@bib5] and the morbidity of PCOS is increasing;[@bib6] thus, it is of significance to study the treatment and mechanisms of PCOS.

Long non-coding RNAs (lncRNAs) were associated with human diseases and played essential roles through interacting with DNA, RNA, protein molecules, and their combinations.[@bib7] A non-coding small RNA is called as microRNA (miRNA), which generally includes about 20 nt and is able to regulate several target genes.[@bib8] In recent years, an amount of lncRNAs and miRNAs were implicated in PCOS, such as lncRNA HOTAIR,[@bib9] miR-23a, and miR-23b.[@bib10] PVT1 has been proved to be situated in 8q24.21 and abnormally expressed in several human diseases, including cervical cancer[@bib11] and ovarian cancer.[@bib12] Furthermore, miR-17-5p is situated in chromosome 13q31, which is involved in breast cancer.[@bib13] Additionally, it had been shown that miR-17-5p was decreased in women with endometriosis compared with those without endometriosis in mainland China,[@bib14] and it also decreased in women with ovarian endometrioma.[@bib15] Phosphatase and tensin homolog (PTEN) has proved to be frequently disrupted in many kinds of tumors and targeted by germline mutations in cancer patients, and it has performed as a tumor inhibitor in some tissues.[@bib16] A recent study has revealed that PTEN participates in cancers,[@bib17] including ovarian cancer,[@bib18] cervical cancer,[@bib19] and endometrial cancer.[@bib20] Interestingly, the relationship between PTEN and polycystic ovary has been revealed by previous research.[@bib21] However, there remains little known about the correlations among PVT1, miR-17-5p, PTEN, and PCOS. Thus, this study was performed to determine the role of the lncRNA PVT1/miR-17-5p/PTEN axis in PCOS, and we speculated that PVT1 may regulate the expression of PTEN, including sex hormone secretion, cell proliferation, as well as apoptosis of ovarian granulosa cells in PCOS by modulating miR-17-5p.

Results {#sec2}
=======

The Levels of SHBG and FSH Are Abated and the Levels of FINS, FPG, LH, and T as well as HOMA-IR Are Increased in PCOS {#sec2.1}
---------------------------------------------------------------------------------------------------------------------

The clinicopathological features of the PCOS patients were analyzed ([Table 1](#tbl1){ref-type="table"}) and we found that there was no evident difference in age and body mass index (BMI) between the PCOS group and the no-PCOS group (both p \> 0.05). The levels of sex hormone-binding globulin (SHBG), LH, follicle-stimulating hormone (FSH), testosterone (T), fasting insulin (FINS), fasting plasma glucose (FPG), homeostatic model assessment of insulin resistance (HOMA-IR), estradiol (E2), and progesterone (P4) were all detected. The results indicated that there was no broad difference in levels of E2 and P4 between the PCOS group and the no-PCOS group (both p \> 0.05); in contrast to the no-PCOS group, the levels of SHBG and FSH were decreased, while the levels of FINS, FPG, LH, and T as well as HOMA-IR were increased in the PCOS group (all p \< 0.05).Table 1Clinicopathological Features of PCOS PatientsClinicopathological CharacteristicsPCOS (n = 70)no-PCOS (n = 70)p ValueAge (year)28.76 ± 4.3327.93 ± 3.750.228BMI (kg/m^2^)26.72 ± 6.7225.41 ± 7.340.273SHBG (nmol/L)31.14 ± 6.9450.23 ± 5.48\<0.001LH (mIU/mL)7.42 ± 0.715.14 ± 0.75\<0.001FSH (mIU/mL)5.21 ± 1.027.18 ± 1.92\<0.001E2 (pg/mL)38.21 ± 13.3135.43 ± 11.280.185T (nmol/L)1.76 ± 0.170.92 ± 0.12\<0.001P4 (ng/mL)0.76 ± 0.410.82 ± 0.520.450FINS (mIU/L)12.75 ± 4.426.75 ± 1.87\<0.001HOMA-IR2.96 ± 1.081.54 ± 0.94\<0.001FPG (mmol/L)5.51 ± 0.914.86 ± 0.63\<0.001[^1]

PVT1 and PTEN Are Increased and miR-17-5p Is Decreased in PCOS Follicular Fluid and Ovarian Granulosa Cells {#sec2.2}
-----------------------------------------------------------------------------------------------------------

The levels of PVT1, PTEN, and miR-17-5p in the follicular fluid and ovarian granulosa cells of the no-PCOS group and the PCOS group were measured by qRT-PCR, and we found that the expression of PVT1 and PTEN was enhanced and the expression of miR-17-5p was reduced relative to the no-PCOS group (all p \< 0.05, [Figures 1](#fig1){ref-type="fig"}A and 1B). The protein expression of PTEN in the follicular fluid and ovarian granulosa cells of the no-PCOS group and the PCOS group was detected by western blot analysis, and the outcomes suggested that in comparison to the no-PCOS group, the protein expression of PTEN was elevated in the PCOS group (p \< 0.05, [Figures 1](#fig1){ref-type="fig"}C and 1D).Figure 1PVT1 and PTEN Are Increased and miR-17-5p Is Decreased in PCOS Follicular Fluid(A) Expression of PVT1, miR-17-5p, and PTEN in follicular fluid in each group. (B) PTEN expression in follicular fluid in each group. (C) Expression of PVT1, miR-17-5p, and PTEN in ovarian granulosa cells. (D) Protein expression of PTEN in ovarian granulosa cells. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the no-PCOS group.

Overexpressed miR-17-5p and Inhibited PVT1 Elevate Contents of E2 and P4 in Ovarian Granulosa Cells in PCOS {#sec2.3}
-----------------------------------------------------------------------------------------------------------

After a 24-h culture, the granulosa cells were irregular in morphology, which were seen as polygonal or fusiform under an inverted microscope, and the results for the FSH receptor (FSHR) revealed that FSHR protein of ovarian granulosa cells, which were labeled by indirect immunofluorescence, was stained green when viewed with a fluorescence microscope, indicating that the extracted cells were ovarian granulosa cells ([Figure 2](#fig2){ref-type="fig"}A).Figure 2Overexpressed miR-17-5p and Inhibited PVT1 Increase the Contents of E2 and P4 in Ovarian Granulosa Cells in PCOS(A) Identification results of FSHR in ovarian granulosa cells. (B and C) Levels of E2 (B) and P4 (C) of ovarian granulosa cells in each group. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the sh-NC group, ^b^p \< 0.05 versus the sh-PVT1 group, ^c^p \< 0.05 versus the mimic NC group, ^d^p \< 0.05 versus the oe-NC group, ^e^p \< 0.05 versus the oe-PVT1 group.

The levels of E2 and P4 of ovarian granulosa cells in each group were detected by enzyme-linked immunosorbent assay (ELISA). The outcomes showed that when contrasted to the short hairpin (sh-)negative control (NC) group, the contents of E2 and P4 were increased in the sh-PVT1 group (both p \< 0.05); relative to the sh-PVT1 group, the contents of E2 and P4 were suppressed in the sh-PVT1 + miR-17-5p inhibitor group (both p \< 0.05); in comparison to the mimic NC group, the contents of E2 and P4 were augmented in the miR-17-5p mimic group (both p \< 0.05); when contrasted to the overexpressed (oe-)NC group, the contents of E2 and P4 were repressed in the oe-PVT1 group (both p \< 0.05); compared with the oe-PVT1 group, the contents of E2 and P4 were enhanced in the oe-PVT1 + miR-17-5p mimic group (both p \< 0.05) ([Figures 2](#fig2){ref-type="fig"}B and 2C).

Overexpressed miR-17-5p and Inhibited PVT1 Accelerate Colony Formation Ability and Proliferation of Ovarian Granulosa Cells in PCOS {#sec2.4}
-----------------------------------------------------------------------------------------------------------------------------------

The colony formation ability of ovarian granulosa cells in each group was measured by a colony formation assay, and proliferation of ovarian granulosa cells in each group was evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide (MTT) assay and a 5-ethynyl-2′-deoxyuridine (EdU) assay. The results showed that the colony formation ability and proliferation of ovarian granulosa cells in the sh-PVT1 group were augmented versus the sh-NC group (both p \< 0.05); relative to the sh-PVT1 group, the colony formation ability and proliferation of ovarian granulosa cells in the sh-PVT1 + miR-17-5p inhibitor group declined (both p \< 0.05); in contrast to the mimic NC group, the colony formation ability and proliferation of ovarian granulosa cells were increased in the miR-17-5p mimic group (both p \< 0.05); compared with the oe-NC group, the colony formation ability and proliferation of ovarian granulosa cells were reduced in the oe-PVT1 group, which could be reversed by miR-17-5p mimic (both p \< 0.05) ([Figures 3](#fig3){ref-type="fig"}A--3E)Figure 3Overexpressed miR-17-5p and Inhibited PVT1 Accelerate Colony Formation Ability and Proliferation of Ovarian Granulosa Cells in PCOS(A) Colony formation ability of ovarian granulosa cells in each group. (B) Cartogram of colony formation ability of ovarian granulosa cells in each group. (C) Cell proliferation of ovarian granulosa cells in each group was detected by an MTT assay. (D) Representative images of ovarian granulosa cells stained by an EdU assay. (E) Cell proliferation of ovarian granulosa cells in each group was detected by an EdU assay. (F) Protein expression of Ki-67 and cyclin D1 of ovarian granulosa cells in each group. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the sh-NC group, ^b^p \< 0.05 versus the sh-PVT1 group, ^c^p \< 0.05 versus the mimic NC group, ^d^p \< 0.05 versus the oe-NC group, ^e^p \< 0.05 versus the oe-PVT1 group.

The levels of proliferation protein Ki-67 and cyclin D1 were assessed by western blot analysis. We found that the levels of Ki-67 and cyclin D1 were enhanced in the sh-PVT1 group, which was contrasted to the sh-NC group (both p \< 0.05); relative to the sh-PVT1 group, the levels of Ki-67 and cyclin D1 were repressed in the sh-PVT1 + miR-17-5p inhibitor group (both p \< 0.05); in contrast to the mimic NC group, the levels of Ki-67 and cyclin D1 were heightened in the miR-17-5p mimic group (both p \< 0.05); the levels of Ki-67 and cyclin D1 in the oe-PVT1 group declined versus the oe-NC group (both p \< 0.05); relative to the oe-PVT1 group, the levels of Ki-67 and cyclin D1 were promoted in the oe-PVT1 + miR-17-5p mimic group (both p \< 0.05) ([Figure 3](#fig3){ref-type="fig"}F).

Overexpressed miR-17-5p and Inhibited PVT1 Decelerate Apoptosis of Ovarian Granulosa Cells in PCOS {#sec2.5}
--------------------------------------------------------------------------------------------------

The cell cycle distribution of each group was determined by flow cytometry, the ratio of cells in G~0~/G~1~ phase declined (p \< 0.05), and the ratio of cells in the S and G~2~/M phases increased (both p \< 0.05) in the sh-PVT1 group, which was compared with the sh-NC group; relative to the sh-PVT1 group, the ratio of cells in the G~0~/G~1~ phase was heightened (p \< 0.05), and the ratio of cells in the S and G~2~/M phases was lowered (both p \< 0.05) in the sh-PVT1 + miR-17-5p inhibitor group; in comparison to the mimic NC group, the ratio of cells in the G~0~/G~1~ phase was reduced (p \< 0.05), and the ratio of cells in S and G~2~/M phases was enhanced (both p \< 0.05) in the miR-17-5p mimic group; when contrasted to the oe-NC group, the ratio of cells in the G~0~/G~1~ phase was enhanced (p \< 0.05), and the ratio of cells in the S and G~2~/M phases decreased (both p \< 0.05) in the oe-PVT1 group, which could be reversed by miR-17-5p mimic ([Figures 4](#fig4){ref-type="fig"}A and 4B).Figure 4Overexpressed miR-17-5p and Inhibited PVT1 Decelerate Apoptosis of Ovarian Granulosa Cells in PCOS(A) Cell cycle distribution of ovarian granulosa cells in each group was detected by flow cytometry. (B) Cartogram of cell cycle distribution of ovarian granulosa cells in each group. (C) Apoptosis of ovarian granulosa cells in each group was detected by flow cytometry. (D) Cartogram of apoptosis of ovarian granulosa cells in each group. (E) Representative images of Hoechst 33258 staining. (F) Apoptosis of ovarian granulosa cells was measured by TUNEL staining. (G) Statistical results of TUNEL staining. (H) Protein expression of cleaved-caspase-3, Bax, and Bcl-2 of ovarian granulosa cells in each group. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the sh-NC group, ^b^p \< 0.05 versus the sh-PVT1 group, ^c^p \< 0.05 versus the mimic NC group, ^d^p \< 0.05 versus the oe-NC group, ^e^p \< 0.05 versus the oe-PVT1 group.

Flow cytometry was employed to detect apoptosis of ovarian granulosa cells in each group. The outcomes illuminated that relative to the sh-NC group, the apoptotic rate in the sh-PVT1 group was reduced (p \< 0.05); the apoptotic rate in the sh-PVT1 group was elevated versus the sh-PVT1 + miR-17-5p inhibitor group (p \< 0.05); in comparison to the mimic NC group, the apoptotic rate in the miR-17-5p mimic group was lowered (p \< 0.05); in contrast to the oe-NC group, the apoptotic rate was heightened in the oe-PVT1 group, and the elevation could be suppressed by miR-17-5p mimic (p \< 0.05) ([Figures 4](#fig4){ref-type="fig"}C and 4D).

As shown by Hoechst 33258 staining, in the sh-NC group, the sh-PVT1 + miR-17-5p inhibitor group, the mimic NC group, the oe-NC group, and the oe-PVT1 + miR-17-5p mimic group, part of the cells were shrunk and lacked integrity, the nuclei were in different levels of dense staining or were shown as fragmented dense staining, condensed cytoplasm was elevated, and part of the apoptosis could be observed; a small amount of apoptotic cells could be found in the sh-PVT1 group and in the miR-17-5p mimic group; hotspots were the most frequent in the oe-PVT1 group, indicating a larger number of apoptotic cells ([Figure 4](#fig4){ref-type="fig"}E).

Terminal deoxynucleotidyltransferase-mediated dUTP (deoxyuridine triphosphate) nick end labeling (TUNEL) staining was employed to assess the cell apoptosis, and the results were in line with those of flow cytometry and Hoechst 33258 staining ([Figures 4](#fig4){ref-type="fig"}F and 4G).

The levels of cleaved-caspase-3, Bax, and Bcl-2 of ovarian granulosa cells in each group were determined by western blot analysis. The outcomes implied that compared with the sh-NC group, the levels of cleaved-caspase-3 and Bax were decreased, while the level of Bcl-2 was enhanced, in the sh-PVT1 group (all p \< 0.05); in contrast to the sh-PVT1 group, the levels of cleaved-caspase-3 and Bax in the sh-PVT1 + miR-17-5p inhibitor group were increased, while the level of Bcl-2 was decreased (all p \< 0.05); relative to the mimic NC group, the levels of cleaved-caspase-3 and Bax declined, while the level of Bcl-2 was advanced in the miR-17-5p mimic group (all p \< 0.05); in comparison to the oe-NC group, the levels of cleaved-caspase-3 and Bax were heightened, while the level of Bcl-2 was reduced, in the oe-PVT1 group; relative to the oe-PVT1 group, the levels of cleaved-caspase-3 and Bax were decreased, while the level of Bcl-2 was enhanced, in the oe-PVT1 + miR-17-5p mimic group (all p \< 0.05) ([Figure 4](#fig4){ref-type="fig"}H).

PVT1 Is Negatively Associated with miR-17-5p in Ovarian Granulosa Cells in PCOS {#sec2.6}
-------------------------------------------------------------------------------

As predicted by a bioinformatics website, PVT1 was mainly expressed in nuclei ([Figure 5](#fig5){ref-type="fig"}A). Results of a fluorescence *in situ* hybridization (FISH) assay have confirmed that PVT1 was localized in nuclei of the ovarian granulosa cells ([Figure 5](#fig5){ref-type="fig"}B).Figure 5PVT1 Is Negatively Associated with miR-17-5p in Ovarian Granulosa Cells in PCOS(A) Subcellular localization of PVT1 was determined by a bioinformatics website. (B) Subcellular localization of PVT1 in ovarian granulosa cells was confirmed by a FISH assay. (C) Expression of PVT1 and miR-17-5p of ovarian granulosa cells in each group. (D) The binding sites of PVT1 and miR-17-5p were predicted by a bioinformatics website. (E) The regulative relationship between PVT1 and miR-17-5p was assessed by a dual-luciferase reporter gene assay. (F) The binding relationship between PVT1 and miR-17-5p was identified by an RNA pull-down assay. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the sh-NC group, ^b^p \< 0.05 versus the sh-PVT1 group, ^c^p \< 0.05 versus the mimic NC group, ^d^p \< 0.05 versus the oe-NC group, ^e^p \< 0.05 versus the oe-PVT1 group.

The expression of PVT1 and miR-17-5p in ovarian granulosa cells in each group was detected by qRT-PCR. We found that relative to the sh-NC group, PVT1 was downregulated (p \< 0.05) and miR-17-5p was upregulated in the sh-PVT1 group (both p \< 0.05); in comparison to the sh-PVT1 group, the expression of PVT1 did not significantly change (p \> 0.05), and the expression of miR-17-5p was reduced in the sh-PVT1 + miR-17-5p inhibitor group (p \< 0.05); when contrasted to the mimic NC group, changes of PVT1 expression were not evident (p \> 0.05), and expression of miR-17-5p was elevated in the miR-17-5p mimic group (p \< 0.05); in contrast to the oe-NC group, PVT1 expression was increased and expression of miR-17-5p was decreased in the oe-PVT1 group (both p \< 0.05); relative to the oe-PVT1 group, PVT1 expression did not apparently vary (p \> 0.05), while miR-17-5p was increased in the oe-PVT1 + miR-17-5p mimic group (p \< 0.05) ([Figure 5](#fig5){ref-type="fig"}C).

As predicted by online software, there was a binding domain between the PVT1 gene sequence and the miR-17-5p sequence ([Figure 5](#fig5){ref-type="fig"}D). According to the outcomes of a dual-luciferase reporter gene assay, relative to the mimic NC group, the luciferase activity of PVT1-wild type (WT) in the miR-17-5p mimic group declined (p \< 0.05), while there was no evident change of the luciferase activity of PVT1-mutant (MUT) in the miR-17-5p mimic group (p \> 0.05), suggesting that there was a binding relationship between PVT1 and miR-17-5p ([Figure 5](#fig5){ref-type="fig"}E).

The results of RNA pull-down detection revealed that in comparison to the Bio-probe NC group, PVT1 expression in the the Bio-miR-17-5p-WT group was elevated (p \< 0.05); no considerable difference could be found in PVT1 expression in the Bio-miR-17-5p-MUT group (p \> 0.05) ([Figure 5](#fig5){ref-type="fig"}F).

PVT1 Is in Competitive Binding with miR-17-5p to Regulate Expression of PTEN in PCOS {#sec2.7}
------------------------------------------------------------------------------------

The expression of PTEN of ovarian granulosa cells in each group was evaluated by qRT-PCR and western blot analysis, the results of which indicated that relative to the sh-NC group, PTEN expression was downregulated in the sh-PVT1 group (p \< 0.05); compared with the sh-PVT1 group, PTEN expression was increased in the sh-PVT1 + miR-17-5p inhibitor group (p \< 0.05); in contrast to the mimic NC group, PTEN expression was lowered in the miR-17-5p mimic group (p \< 0.05); in comparison to the oe-NC group, PTEN expression was elevated in the oe-PVT1 group (p \< 0.05); and PTEN was decreased in the oe-PVT1 + miR-17-5p mimic group, which was relative to the oe-PVT1 group (p \< 0.05) ([Figures 6](#fig6){ref-type="fig"}A and 6B).Figure 6PVT1 Is in Competitive Binding with miR-17-5p to Regulate Expression of PTEN in PCOS(A) mRNA expression of PTEN of ovarian granulosa cells in each group. (B) Protein expression of PTEN of ovarian granulosa cells in each group. (C) Binding sites of PVT1 and miR-17-5p were predicted by a bioinformatics website. (D) The regulative relation between PVT1 and miR-17-5p was assessed by a dual-luciferase reporter gene assay. (E) Ovarian granular cells overexpressing miR-17-5p were conducted with Ago2/RISC immunoprecipitation by Pan-Ago2 antibody; IgG was used as a negative control, and GAPDH was used as an internal control. (F) miR-17-5p and PTEN were introduced to the PCR analysis of RISC in ovarian granular cells overexpressing miR-17-5p. The data were all measurement data and are expressed as mean ± standard deviation. ^a^p \< 0.05 versus the sh-NC group, ^b^p \< 0.05 versus the sh-PVT1 group, ^c^p \< 0.05 versus the mimic NC group, ^d^p \< 0.05 versus the oe-NC group, ^e^p \< 0.05 versus the oe-PVT1 group.

The target relationship between miR-17-5p and PTEN was predicted by a bioinformatics software (<http://www.targetscan.org>) ([Figure 6](#fig6){ref-type="fig"}C). The outcomes of a dual-luciferase reporter assay implied that after PTEN-WT and miR-17-5p were co-transfected with ovarian granulosa cells, the relative luciferase activity was evidently decreased (p \< 0.05), whereas the co-transfection of PTEN-MUT and miR-17-5p was not related to the relative luciferase activity of the cells (p \> 0.05) ([Figure 6](#fig6){ref-type="fig"}D). We next detected the PTEN mRNA abundance in the Ago2/RNA-RNA-induced silencing complex (RISC) after overexpression of miR-17-5p by using RNA-chromatin immunoprecipitation (ChIP) analysis ([Figure 6](#fig6){ref-type="fig"}E). Enrichment in the level of miR-17-5p and PTEN that incorporated into RISC was observed in miR-17-5p mimic-transfected cells ([Figure 6](#fig6){ref-type="fig"}F).

Discussion {#sec3}
==========

PCOS is a kind of common endocrine disease, and patients affected usually have difficulty with fertility caused by sex hormone disturbance.[@bib22] It has been shown that miRNAs, which were characterized as small non-coding RNAs, played a role of leading molecules in RNA silencing.[@bib23] This study was performed to determine the role of the lncRNA PVT1/miR-17-5p/PTEN axis in PCOS, and we found that PVT1 could regulate the expression of PTEN and progression of PCOS by modulating miR-17-5p.

Among the important findings of our study, we found the disorder of glucose metabolism status and sex hormones in PCOS. For instance, SHBG and FSH were decreased in PCOS, whereas FINS, FPG, LH, and T, as well as HOMA-IR, were increased in PCOS. There were no evident difference in concentrations of E2 and P4 between PCOS and no-PCOS patients, and a similar outcome was found in other studies.[@bib24], [@bib25], [@bib26], [@bib27], [@bib28] A previous study revealed that SHBG is a candidate gene of PCOS,[@bib29] and FSH has been proven to function as a predictor of diagnosis of PCOS.[@bib30] Moreover, the correlation between PCOS and P4 has also been revealed in a prior study.[@bib31] We also found that PVT1 and PTEN were increased, whereas the expression of miR-17-5p was decreased, in follicular fluid of patients with PCOS. Similar to this finding, the serum PVT1 level was verified to increase in cervical cancer patients,[@bib32] and PTEN has also been identified to be overexpressed in an ovarian cancer cell line.[@bib18] Furthermore, according to existing research, the downregulation of miR-17-5p was also found in women with endometriosis.[@bib14]

Another essential result of this study was that the downregulation of PVT1 together with upregulation of miR-17-5p could promote the sex hormone secretion in ovarian granulosa cells in PCOS. Similarly, a recent study proved that miR-17-5p could promote estrogen synthesis,[@bib33] and it has been demonstrated that the suppression of PTEN can increase the release of P4 in spent media[@bib34] and that PTEN is the target gene of miR-17-5p. In conclusion, miR-17-5p is able to promote the secretion of E2 and P4, and this result is in accordance with ours. Wang et al.[@bib35] have found by using microarray analysis that there is regulatory relationship between the content of T and expression of miR-17. Moreover, we have found that inhibited PVT1 and elevated miR-17-5p can promote the colony formation ability and proliferation activity of ovarian granulosa cells in PCOS. In line with this outcome, it has been shown by a study that miR-17-5p suppresses proliferation and migration of human breast cancer cells.[@bib13] Another study has revealed that upregulation of PVT1 induced viability of ovarian cancer cells.[@bib12] Furthermore, it has been clarified in our research that the knockdown of PVT1 and overexpression of miR-17-5p can attenuate the apoptosis of ovarian granulosa cells. This finding is in accordance with recent research reporting that miR-17-5p was able to induce the apoptosis of breast cancer cells.[@bib36] Extant research has also proven that cervical cells that had been treated with silenced PVT1 exhibited a significant increase in cell death and apoptosis.[@bib37] The last finding of this study suggested that PVT1 was negatively correlated with miR-17-5p, and that PVT1 could competitively bind with miR-17-5p, resulting in the promotion of PTEN. According to recent research, miR-17-5p was found to have the capacity to induce the progression of hepatocellular carcinoma by modulating PTEN.[@bib38] Additionally, Gu et al.[@bib39] have shown that miR-17-5p could be enhanced by the amplification of PTEN, which was led by high growth factor receptor α~2~ in pancreatic cancer. All of these data helped to recognize the effects of lncRNA PVT1, PTEN, and miR-17-5p on human diseases.

In conclusion, this study has proven that PVT1 and PTEN were increased and miR-17-5p was downregulated in PCOS follicular fluid, and that inhibited PVT1 could elevate miR-17-5p, thereby reducing the expression of PTEN and promoting cell proliferation, as well as decelerating apoptosis of ovarian granulosa cells in PCOS. Nevertheless, more methods are required to further investigate the function and mechanisms of the lncRNA PVT1/miR-17-5p/PTEN axis in PCOS. Additionally, we intend to further investigate the mechanisms of PVT1 in biological functions of ovarian granulosa cells in PCOS.

Materials and Methods {#sec4}
=====================

Ethics Statement {#sec4.1}
----------------

Written informed consent was obtained from all patients prior to the study. The protocols of this study were approved by the Ethics Committee of Luoyang Central Hospital Affiliated to Zhengzhou University and are based on the ethical principles for medical research involving human subjects of the Declaration of Helsinki.

Study Subjects {#sec4.2}
--------------

70 patients (mean age, 28.76 ± 4.33 years old) with PCOS as well as 70 no-PCPS patients (mean age, 27.93 ± 3.75 years old) who received in vitro fertilization and embryo transfer due to issues with fallopian tubes or male infertility in Luoyang Central Hospital Affiliated to Zhengzhou University were enrolled in our study. All PCOS cases met the 2003 Rotterdam criteria[@bib40] and were confirmed by pathological diagnosis. Inclusive criteria included the following: (1) regular menstrual cycle, (2) normal endocrine secretion, and (3) no abnormal sonographic changes in polycystic ovaries, hysteromyoma, and endometriosis under B-ultrasound, and without a family history of hypertension and diabetes.

Collection of Serum and Detection of Hormone Levels {#sec4.3}
---------------------------------------------------

Fasting venous blood was collected on the third through seventh day of menstrual onset or withdrawal bleeding. The level of SHBG was measured by electrochemiluminescence, the levels of LH, T, and FSH were detected by radioimmunoassay, and the levels of E2, P4, HOMA-IR, FPG, and FINS were evaluated with an ELISA. The kits were all obtained from Nanjing Xinfan Biology (Nanjing, China).

Cell Culture and Identification {#sec4.4}
-------------------------------

Oocyte-corona radiata cell-cumulus cell complexes were extracted based on the criteria of oocyte retrieval, and the remaining follicular fluid containing ovarian granulosa cells was collected. The first tube of clear follicular fluid without blood contamination was preserved in a sterile tube for the experiments. The purified granulosa cells were collected by density gradient centrifugation, the steps of which were as follows: follicular fluid containing granulosa cells was centrifuged at 2,000 rpm for 10 min, with supernatant being discarded; the remainder was resuspended with 1 mL of hyaluronidase, conducted in a water bath at 37°C for 20 min; then, the cell suspension was transferred onto the surface of 4 mL of lymphocyte separation liquid and centrifuged again; the white cloudy cell clusters in the middle area were granulosa cells.

The cell concentration was adjusted to 2 × 10^5^ to 4 × 10^5^ cells/mL by Dulbecco's modified Eagle's medium (DMEM)/F12 containing 10% fetal bovine serum (FBS); the cells were seeded on six-well plates with 1 × 10^5^ to 2 × 10^5^ cells/well and incubated at 37°C with 5% CO~2~ for 48 h. The culture solution was discarded and 2 mL of DMEM/F12 medium was added in each well for subsequent culture.

Expression of FSHR was used to identify the cells: cells in the fourth day of well growth were detached by 0.25% trypsin-0.02% ethylenediaminetetraacetic acid (EDTA), and then the cells were collected after centrifugation at 1,000 rpm for 8 min with supernatant discarded, and made into 2.5 × 10^4^ cells/mL cell suspensions. The cells were seeded on culture plates, 4% formaldehyde was added when the cell confluence reached 70%, and then cells were rinsed with phosphate-buffered saline (PBS) twice. For immunohistochemical staining, the cells were appended with primary antibody, that is, FSHR rabbit polyclonal antibody (1:200) at 40°C overnight, and then supplemented with 5 mL of annexin V-fluorescein isothiocyanate (FITC)-marked secondary anti-rabbit immunoglobulin G (IgG) and 4′,6-diamidino-2-phenylindole-2 HCl (DAPI), incubated without light exposure for 60 min, washed three times with PBS for 5 min, and then the cells were observed and imaged under a fluorescence microscope.

Cell Grouping {#sec4.5}
-------------

PCOS ovarian granulosa cells were separated into the sh-NC group (cells transfected with NC of silenced PVT1 plasmid), the sh-PVT1 group (cells transfected with silenced PVT1 plasmid), the mimic NC group (cells transfected with miR-17-5p mimic NC), the miR-17-5p mimic group (cells transfected with miR-17-5p mimic), the oe-NC group (cells transfected with NC of overexpressed PVT1 plasmid), the oe-PVT1 group (cells transfected with overexpressed PVT1 plasmid), the sh-PVT1 + miR-17-5p inhibitor group (cells transfected with silenced PVT1 plasmid and miR-17-5p inhibitor), and the oe-PVT1 + miR-17-5p mimic group (cells transfected with overexpressed PVT1 plasmid and miR-17-5p mimic). The cells were seeded onto six-well plates at 2 × 10^5^ cells/well; when cell confluence reached 80%, the cells were transfected with Lipofectamine 2000 reagent (11668-027, Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions, the sequences were diluted with 250 μL of serum-free DMEM/F12 medium (all from Shanghai GenePharma, Shanghai, China) and incubated for 5 min, and the above two were mixed and incubated for 20 min and paved into the wells. The cells were incubated at 37°C with 5% CO~2~ and saturated humidity for 6 h, and the medium was replaced with DMEM/F12 culture solution containing 10% FBS for 24 h for the subsequent experiments.

MTT Assay {#sec4.6}
---------

Ovarian granulosa cells (1 mL) in the logarithmic growth phase were seeded onto 96-well plates at 1 × 10^5^ cells/mL and incubated for 24 h. The medium was replaced by 200 μL of DMEM/F12 medium containing 10% FBS after cell adherence, and then the cells were added to 20 μL of MTT solution (5 mg/mL) and incubated at 37°C for 4 h. With supernatant discarded, each well was appended with 150 μL of dimethyl sulfoxide (DMSO) and shaken for 10 min, after which the optical density (OD) value at a wavelength of 490 nm was detected by a microplate reader.

EdU Assay {#sec4.7}
---------

The transfected cells were made into a serum-free single-cell suspension, which was seeded onto 24-well plates at 5.0 × 10^4^ cells/well; 3 wells were set in each group, and then the cells were incubated at 37°C with 5% CO~2~ for 24 h. The culture solution was replaced by serum-free DMEM/F12 medium containing 1:1000 EdU for the 2-h incubation. The steps were based on the directions of EdU kit (Nanjing XinFan Biology, Nanjing, China). Three random fields of view were observed and imaged by an inverted fluorescence microscope. The blue fluorescence expressed all of the cells, and the red fluorescence expressed duplicating cells that were penetrated with EdU. The percentage of EdU-positive cells was calculated.

Flow Cytometry {#sec4.8}
--------------

Cells of each group were collected and part of the cells were added with 100 μL of propidium iodide (PI)-RNase A for a 15-min incubation without light exposure, and the difference of DNA contents in each passage of the cell cycle was analyzed by flow cytometry. After cells were detached and centrifuged, they were rinsed with PBS twice and resuspended in 75% ethanol, fixed at −20°C overnight, and then centrifuged, with the supernatant being discarded. The cells were washed with PBS twice, and each sample was resuspended in 450 μL of PBS, supplemented with 100 μL of RNase A at 37°C, conducted in a water bath at 37°C for 30 min, and appended with 400 μL of PI for staining, which was done at 4°C without light exposure for 30 min. The cell cycle distribution was measured and analyzed by a flow cytometry (FACSCalibur, Becton Dickinson, NJ, USA).

Cells in each group were rinsed three times with PBS and resuspended by appending with 100 μL of precooled 1× binding buffer, added with 5 μL of annexin V and 5 μL of PI in order, and then mixed and incubated without light exposure for 15 min. The apoptosis was determined by flow cytometry. Annexin V was taken as the abscissa axis and PI was taken as the longitudinal axis: the left upper quadrant included mechanical injured cells, the right upper quadrant included advanced apoptotic cells or necrotic cells, the left lower quadrant included negative normal cells, and the right lower quadrant included early apoptotic cells.

Hoechst 33258 Staining {#sec4.9}
----------------------

The transfected cells were seeded onto 24-well plates at 5.0 × 10^4^ cells/mL, incubated at 37°C with 5% CO~2~ for 24 h, and then fixed with 4% paraformaldehyde for 10 min, washed with PBS twice (5 min/time), and added with Hoechst 33258 (final concentration, 10 mg/L) for 10-min staining without light exposure. The cells were observed with an excitation wavelength at 350 nm and an emission wavelength at 460 nm under a fluorescence microscope. Six random fields of view of each well were selected, and 200 cells were counted and the apoptotic rate was calculated.

TUNEL Staining {#sec4.10}
--------------

Ovarian granulosa cells were seeded into 24-well plates at 5 × 10^4^ cells/mL and incubated in DMEM containing 10% FBS and 1% streptomycin. The slides were treated with diluted protease K for 30 min, and cells in the experimental groups were added with TUNEL reaction solution (Roche, Basel, Switzerland; 50 μL TdT \[terminal deoxynucleotidyltransferase\] mixed with 450 μL of fluorescein-labeled dUTP); cells in the NC group were appended with 50 μL of fluorescein-labeled dUTP, and positive cells were supplemented with 50 μL of DNase I loading buffer. The cells were sealed by glycerinum and observed under a fluorescence microscope. Twenty fields of view were randomly selected for cell counting.

Colony Formation Assay {#sec4.11}
----------------------

Cells of each group were seeded in 60-mm culture dishes (containing 10 mL of culture solution) at 200 cells/dish and incubated at 37°C with 5% CO~2~; the cell colony formation was visible after 14 d. With culture solution discarded, the cells were fixed with 4% paraformaldehyde for 15 min and stained by 0.1% crystal violet for 20 min. The number of cell colonies (\>50 expressed for an effective colony) in five fields of view were randomly selected. The cell colony formation rate is equal to the number of colonies/number of seeded cells × 100%.

qRT-PCR {#sec4.12}
-------

The total RNA of follicular fluid and ovarian granulosa cells was extracted by TRIzol (Invitrogen, Carlsbad, CA, USA), and cDNA was obtained with a reverse transcription kit. PCR primers ([Table 2](#tbl2){ref-type="table"}) were designed and synthetized by Beijing ComWin Biotech (Beijing, China). The PCR was conducted according to the instruments of SYBR Green PCR kits (TransGen, Beijing, China) on a 7000 Sequence Detection System (Applied Biosystems, CA, USA). Glyceraldehyde phosphate dehydrogenase (GAPDH) was taken as the internal reference (U6 was taken as the internal reference of endonuclear RNA and miR-17-5p). The products were verified by agarose gel electrophoresis. The threshold value was selected at the lowest point of each logarithmic amplification curve to obtain the threshold cycle (Ct) value of each reaction tube, and data were analyzed by the 2^−ΔΔCt^ method.Table 2Primer SequencesGeneSequencePVT1F: 5′-TGAGAACTGTCCTTACGTGACC-3′R: 5′-AGAGCACCAAGACTGGCTCT-3′miR-17-5pF: 5′-TGCGGCAAAGTGCTTACAGTG-3′R: 5′-CCAGTGCAGGGTCCGAGGT-3′U6F: 5′-CTCGCTTCGGCAGCACA-3′R: 5′-AACGCTTCACGAATTTGCGT-3′PTENF: 5′-GATGGCACTTTCCCGTTTTA-3′R: 5′-TCTGAGCATTCCCTCCATTC-3′GAPDHF: 5′-ACCACCATGGAGAAGGCTGG-3′R: 5′-CTCAGTGTAGCCCAGGATGC-3′[^2]

Western Blot Analysis {#sec4.13}
---------------------

The total protein was extracted and the concentration was detected by a bicinchoninic acid (BCA) kit (Wuhan Boster Biological Technology, Hubei, China). The extracted protein was added with loading buffer (30 μg/well) and boiled at 95°C for 10 min, and then conducted with electrophoretic separation by 10% polyacrylamide gel (Wuhan Boster Biological Technology, Hubei, China) and transferred onto polyvinylidene fluoride (PVDF) transmembranes and fixed by 5% bovine serum albumin (BSA) for 1 h. The protein was added with primary antibodies Ki-67 (1:1,000, Abcam, Cambridge, MA, USA), cyclin D1, cleaved caspase-3, Bax, Bcl-2, PTEN (all 1:1,000 and from Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-pan-Ago antibody, clone 2A8 (1:1,000, Millipore, MA, USA), and GAPDH (1:2,000, Jackson ImmunoResearch, PA, USA), incubated at 4°C for 24--48 h, and placed in secondary antibody, which was marked by horseradish peroxidase (1:500, Jackson ImmunoResearch, PA, USA) and then incubated for 1 h. The images were obtained by an Odyssey two-color infrared fluorescence scanning imaging system. The gray value was analyzed by Quantity One imaging analysis software.

FISH Assay {#sec4.14}
----------

A bioinformatics website (<http://lncatlas.crg.eu/>) was used to predict the subcellular localization of PVT1 in ovarian granulosa cells. The cellular localization of PVT1 in ovarian granulosa cells was assessed by lncRNA FISH probe mix and matching kits (RiboBio, Guangdong, China). The cells were seeded into 24-well plates at 5 × 10^3^ cells/well for a 24-h incubation with the supernatant discarded, fixed by 4% paraformaldehyde, added with PBS containing 0.5% Triton X-100, blocked by prehybridization solution at 37°C, and then supplemented with PVT1 probe at 37°C overnight. After staining with DAPI, the samples were sealed without light exposure and observed with a confocal laser scanning microscope.

Dual-Luciferase Reporter Gene Assay {#sec4.15}
-----------------------------------

The binding sites of lncRNA PVT1 and miR-17-5p were predicted by a bioinformatics website (<https://cm.jefferson.edu/rna22/Precomputed/>). The binding relationship between PVT1 and miR-17-5p was assessed by a luciferase reporter assay in which an artificially synthesized PVT1 3′ untranslated region (UTR) gene segment was introduced in pMIR-reporter (Beijing Huayueyang Biotech, Beijing, China) by endonuclease sites Bamh1 and Ecor1. The complementary sequence mutation sites of the seed sequence that was designed in the PVT1 wild sequence were conducted with restriction endonuclease and were inserted in pMIR-reporter reporter plasmids. The correctly identified reporter plasmids WT and MUT type were respectively co-transfected with mimics NC and miR-17-5p mimic into ovarian granulosa cells (Shanghai Beinuo Biotech, Shanghai, China). The lysed cells were collected after 48 h of transfection, and the luciferase activity was determined by a luciferase detection kit (BioVision Technologies, San Francisco, CA, USA) and a GloMax 20/20 luminometer (Promega, Madison, WI, USA).

The target relationship of miR-17-5p and PTEN as well as the binding sites of miR-17-5p and PTEN 3′ UTR were all predicted by bioinformatics software (<http://www.targetscan.org/vert_72/>). The PTEN 3′ UTR promoter region sequence containing binding sites of miR-17-5p was synthesized and PTEN 3′ UTR WT plasmid (PTEN-WT) was established, on the basis of which PTEN 3′ UTR MUT plasmid (PTEN-MUT) was established. Ovarian granular cells in the logarithmic growth phase were seeded onto 96-well plates and transfected by Lipofectamine 2000. When the cell confluence reached 70%, PTEN-WT and PTEN-MUT plasmids were respectively mixed with the mimics NC and miR-17-5p and then co-transfected into ovarian granulosa cells for 48 h. The cells were lysed and the luciferase activity was determined by a luciferase detection kit.

RNA Pull-Down Assay {#sec4.16}
-------------------

Biotin-labeled miR-17-5p WT plasmid (50 nM) and biotin-labeled miR-17-5p MUT plasmid (50 nM) were respectively transfected into the cells for 48 h, the cells were collected and rinsed with PBS and incubated by a particular cell lysis buffer (Ambion, Austin, TX, USA) for 10 min, and then a 50-mL sample of cell lysis buffer was subpackaged. The remaining lysate was co-incubated with M-280 streptavidin-coated magnetic beads, which were pre-coated with RNase-free and yeast tRNA (both from Sigma, St. Louis, MO, USA) at 4°C for 3 h. An antagonistic miR-17-5p probe was set as a NC. The total RNA was extracted by TRIzol, and the expression of PVT1 was evaluated by qRT-PCR.

Isolation of RISC-Associated RNA {#sec4.17}
--------------------------------

The ovarian granular cells that had been transfected with miR-17-5p mimic or mimic NC were seeded into six-well plates; then, the medium was removed and the cells were fixed with 1% formalin when the cell confluence reached 80%. The cells were lysed with NETN buffer (20 mM Tris HCl \[pH = 7.9\], 100 mM NaCl, 1 mM EDTA and 0.5% NP-40) and cultured with Dynabeads protein A (Invitrogen) supplemented with IgG or anti-pan-Ago, clone 2A8 antibody. Proteinase K detachment was utilized to release immunoprecipitated RNA, and phenol/chloroform/isopropyl alcohol was adopted for extracting RNA. RNA was then purified by ethanol precipitation with glycogen and treated with DNase I.

Statistical Analysis {#sec4.18}
--------------------

All data analyses were conducted using SPSS 21.0 software (IBM-SPSS, Chicago, IL, USA). The measurement data conforming to the normal distribution were expressed as mean ± standard deviation. The unpaired t test was performed for comparisons between two groups, one-way analysis of variance (ANOVA) was used for comparisons among multiple groups, and a Tukey's multiple comparisons test was used for pairwise comparisons after the ANOVA. A p value \<0.05 was indicative of a statistically significant difference.
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[^1]: PCOS, polycystic ovary syndrome; BMI, body mass index; SHBG, sex hormone-binding globulin; LH, luteinizing hormone; FSH, follicle-stimulating hormone; E2, estradiol; T, testosterone; P4, progesterone; FINS, fasting insulin; HOMA-IR, homeostatic model assessment of insulin resistance; FPG, fasting plasma glucose. The measurement data conforming to the normal distribution are expressed as mean ± standard deviation and the unpaired t test was performed for comparisons between two groups.

[^2]: F, forward; R, reverse; PVT1, plasmacytoma variant translocation gene; miR-17-5p, microRNA-17-5p; PTEN, phosphatase and tensin homolog deleted on chromosome 10; GAPDH, glyceraldehyde phosphate dehydrogenase.
